We are live on
!
Find out more
ACM
Arvin Capital Management Portfolio holdings
AUM
$819M
1-Year Est. Return
24.75%
This Fund
S&P 500
This Quarter
Est. Return
+12.12%
1 Year Est. Return
+24.75%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$227M
AUM Growth
–
Cap. Flow
+$205M
Cap. Flow
% of AUM
90.59%
Top 10 Holdings %
Top 10 Hldgs %
59.26%
Holding
29
New
29
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Lamb Weston
LW
|
+$14.9M |
| 2 |
Avantor
AVTR
|
+$14.9M |
| 3 |
Fidelity National Information Services
FIS
|
+$13.7M |
| 4 |
Nutanix
NTNX
|
+$13.6M |
| 5 |
XPO
XPO
|
+$12.2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 15.94% |
| 2 | Healthcare | 15.78% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.78% |
| 5 | Financials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Lamb Weston
LW
$6.46B
| $16.7M | 7.39% |
+154,924
| New | +$14.9M |
|
|
2
Avantor
AVTR
$7.59B
| $16.6M | 7.31% |
+725,553
| New | +$14.9M |
|
|
3
Nutanix
NTNX
$14.9B
| $16M | 7.06% |
+335,622
| New | +$13.6M |
|
|
4
Fidelity National Information Services
FIS
$21.6B
| $15M | 6.6% |
+248,912
| New | +$13.7M |
|
|
5
XPO
XPO
$25.5B
| $13.1M | 5.79% |
+149,646
| New | +$12.2M |
|
6
TransUnion
TRU
$15.3B
| $12.7M | 5.59% |
+184,394
| New | +$11.2M |
|
7
CALL
JD.com
JD
$40.2B
| $11.8M | 5.19% |
+407,000
| New | +$11M |
|
8
Teck Resources
TECK
$27.4B
| $11.4M | 5.02% |
+269,324
| New | +$10.3M |
|
9
Janus International
JBI
$735M
| $11.3M | 4.99% |
+867,051
| New | +$9.22M |
|
|
10
JD.com
JD
$40.2B
| $9.75M | 4.3% |
+337,314
| New | +$9.14M |
|
11
Burlington
BURL
$22B
| $9.09M | 4.01% |
+46,731
| New | +$6.97M |
|
|
12
CALL
Avantor
AVTR
$7.59B
| $7.99M | 3.53% |
+350,000
| New | +$7.17M |
|
13
Meta Platforms (Facebook)
META
$1.61T
| $6.85M | 3.02% |
+19,347
| New | +$6.3M |
|
14
CALL
Bio-Rad Laboratories Class A
BIO
$8.02B
| $6.46M | 2.85% |
+20,000
| New | +$6.27M |
|
|
15
Bio-Rad Laboratories Class A
BIO
$8.02B
| $5.87M | 2.59% |
+18,184
| New | +$5.7M |
|
16
Transocean
RIG
$5.67B
| $5.87M | 2.59% |
+923,875
| New | +$6.18M |
|
17
CALL
Gildan
GIL
$9.95B
| $5.79M | 2.55% |
+175,000
| New | +$5.67M |
|
18
Microsoft
MSFT
$2.91T
| $5.16M | 2.28% |
+13,726
| New | +$4.89M |
|
19
Envista
NVST
$4.35B
| $5.09M | 2.25% |
+211,545
| New | +$5.06M |
|
20
Freeport-McMoran
FCX
$84.9B
| $4.99M | 2.2% |
+117,249
| New | +$4.33M |
|
21
Charles River Laboratories
CRL
$10.8B
| $4.74M | 2.09% |
+20,061
| New | +$3.95M |
|
22
Amazon
AMZN
$2.67T
| $4.01M | 1.77% |
+26,380
| New | +$3.7M |
|
23
Thermo Fisher Scientific
TMO
$199B
| $3.48M | 1.53% |
+6,549
| New | +$3.17M |
|
24
ACV Auctions
ACVA
$1.29B
| $3.37M | 1.49% |
+222,761
| New | +$3.26M |
|
|
25
CALL
Lamb Weston
LW
$6.46B
| $3.24M | 1.43% |
+30,000
| New | +$2.89M |
|
Similar funds
NCM
SIC
MGI
BC
DI
AC
AIMC
CCM
Arvin Capital Management's Q4 2023 Portfolio in Review
Q4 2023 is the first quarter with a 13F filing on record for Arvin Capital Management, which disclosed 29 positions worth $227M. Its ten largest holdings account for 59% of the portfolio.
Its largest position is Lamb Weston: 154,924 shares worth $16.7M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, followed by Healthcare and Consumer Discretionary.
- Arvin Capital Management's largest Q4 2023 buy was Lamb Weston: 154,924 shares worth $16.7M.
- Arvin Capital Management's ten largest holdings make up 59% of its $227M portfolio in Q4 2023.
- Arvin Capital Management disclosed 29 positions in Q4 2023, its first 13F filing on record.
Based on Arvin Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.